Cargando…
The dosing conundrum of emicizumab: To waste product or not?
Autor principal: | Young, Guy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9999193/ https://www.ncbi.nlm.nih.gov/pubmed/36908771 http://dx.doi.org/10.1016/j.rpth.2023.100087 |
Ejemplares similares
-
Optimizing maintenance dosing of emicizumab-kxwh as prophylaxis in hemophilia A: Dosing to product labeling while minimizing drug waste
por: D’Albini, Lesley, et al.
Publicado: (2023) -
Deciphering the vedolizumab dosing conundrum in IBD: when less is more
por: Adolph, Timon Erik, et al.
Publicado: (2022) -
The efficacy of the entire-vial dosing of emicizumab: Real-world evidence on plasma concentrations, bleeds, and drug waste
por: Donners, Anouk A.M.T., et al.
Publicado: (2023) -
The Continuing Fellowship Conundrum
por: Powell, Suzanne Zein-Eldin, et al.
Publicado: (2018) -
The Long COVID Conundrum
por: Gaffney, Adam W.
Publicado: (2022)